Despite a plethora of new and promising treatments available, lung
cancer remains the leading cause of cancer death in the United States,
and will claim more than 150,000 lives this year. November is Lung
Cancer Awareness Month, a time to bring the disease into focus and
educate people about prevention, screening and treatments that save
lives.
MD Anderson’s Lung Cancer Moon Shot™ team is committed to making new, patient-guided...
Pancreatic cancer is one of the most lethal types of cancer, expected to kill more than 44,000 people in the U.S. this year. It’s a deadly...
MD Anderson’s Moon Shots Program™ was established to bring teams of world-class clinicians and researchers together in order to rapidly advance...
Minimally invasive hysterectomies, which are known for shorter, less
stressful recovery periods, are considered easier on patients. But two
studies recently published in the New England Journal of Medicine show
minimally invasive radical hysterectomies aren’t as safe as
traditional abdominal radical hysterectomies for early-stage cervical
cancer patients.
The randomized-controlled Phase III study — led by Pedro Ramirez, M.D...
Triple-negative breast cancer (TNBC) makes up 15 to 20 percent of breast cancer diagnoses. The condition often is considered a single disease...
Over the past decade, immune checkpoint inhibitors have shown success in treating several types of cancer, including melanoma, non-small cell...
MD Anderson researchers have discovered that a protein called angiogenin (ANG) serves as a potential biomarker useful for stratifying pancreatic...
Somatic mutations in certain genes may function as a molecular minimal residual disease marker for acute myeloid leukemia (AML), according...
Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) encompass a spectrum of diseases characterized by an overproduction of immature...
September is Ovarian Cancer Awareness Month, an annual time to bring attention to the impact of the disease. This year, more than 22,000 women...